Latest papers

Thiopurine therapy in inflammatory bowel disease.

[Effective made of octreotide intravenous administration for malignant gastrointestinal obstruction in terminal cancer patients].

[Levosulpiride in the management of functional dyspepsia and delayed gastric emptying].

[Cardiac safety of cinitapride].

Infliximab administered with shortened infusion times in a specialized IBD infusion unit: A prospective cohort study

Emergence of Crohn's disease in juvenile idiopathic arthritis during treatment with etanercept: a causal link or a mere coincidence?

Medical management of variceal hemorrhage.

[Miniinvasive interventions for focal liquid accumulations in region of pancreas and surrounding tissues].

Current and emerging strategies for treating hepatic encephalopathy.

A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.

Transient menorrhagia without adalimumab discontinuation in a patient with Crohn's disease.

Trends in surgery for Crohn's disease in the era of infliximab.

A case of hereditary hemorrhagic telangiectasia associated with Crohn's disease successfully treated with infliximab.

Treatment options for primary sclerosing cholangitis.

Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease.

Rifaximin treatment in hepatic encephalopathy.

Rifaximin treatment in hepatic encephalopathy.

Management of functional abdominal pain and irritable bowel syndrome in children and adolescents.

Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease.

Mesalamine protects against colorectal cancer in inflammatory bowel disease.